HCA Healthcare Inc. (HCA)
HCA Healthcare Statistics
Share Statistics
HCA Healthcare has 246.2M shares outstanding. The number of shares has increased by -6% in one year.
Shares Outstanding | 246.2M |
Shares Change (YoY) | -6% |
Shares Change (QoQ) | -2.8% |
Owned by Institutions (%) | 60.49% |
Shares Floating | 174.51M |
Failed to Deliver (FTD) Shares | 19.81K |
FTD / Avg. Volume | 1.14% |
Short Selling Information
The latest short interest is 5.58M, so 2.25% of the outstanding shares have been sold short.
Short Interest | 5.58M |
Short % of Shares Out | 2.25% |
Short % of Float | 3.14% |
Short Ratio (days to cover) | 3.74 |
Valuation Ratios
The PE ratio is 13.48 and the forward PE ratio is 11.98. HCA Healthcare's PEG ratio is 0.86.
PE Ratio | 13.48 |
Forward PE | 11.98 |
PS Ratio | 1.1 |
Forward PS | 0.9 |
PB Ratio | -31.02 |
P/FCF Ratio | 13.76 |
PEG Ratio | 0.86 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for HCA Healthcare.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of -18.08.
Current Ratio | 1.08 |
Quick Ratio | 0.97 |
Debt / Equity | -18.08 |
Debt / EBITDA | 3.26 |
Debt / FCF | 8.02 |
Interest Coverage | 5.12 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $312.4K |
Profits Per Employee | $25.49K |
Employee Count | 226,000 |
Asset Turnover | 1.19 |
Inventory Turnover | 24.12 |
Taxes
Income Tax | 1.87B |
Effective Tax Rate | 21.89% |
Stock Price Statistics
The stock price has increased by 9.8% in the last 52 weeks. The beta is 1.49, so HCA Healthcare's price volatility has been higher than the market average.
Beta | 1.49 |
52-Week Price Change | 9.8% |
50-Day Moving Average | 327.86 |
200-Day Moving Average | 345.83 |
Relative Strength Index (RSI) | 51.04 |
Average Volume (20 Days) | 1.73M |
Income Statement
In the last 12 months, HCA Healthcare had revenue of 70.6B and earned 5.76B in profits. Earnings per share was 22.27.
Revenue | 70.6B |
Gross Profit | 28.68B |
Operating Income | 10.55B |
Net Income | 5.76B |
EBITDA | 13.86B |
EBIT | 10.58B |
Earnings Per Share (EPS) | 22.27 |
Balance Sheet
The company has 1.93B in cash and 45.24B in debt, giving a net cash position of -43.3B.
Cash & Cash Equivalents | 1.93B |
Total Debt | 45.24B |
Net Cash | -43.3B |
Retained Earnings | -2.12B |
Total Assets | 59.51B |
Working Capital | 1.24B |
Cash Flow
In the last 12 months, operating cash flow was 10.51B and capital expenditures -4.88B, giving a free cash flow of 5.64B.
Operating Cash Flow | 10.51B |
Capital Expenditures | -4.88B |
Free Cash Flow | 5.64B |
FCF Per Share | 21.81 |
Margins
Gross margin is 40.62%, with operating and profit margins of 14.94% and 8.16%.
Gross Margin | 40.62% |
Operating Margin | 14.94% |
Pretax Margin | 12.07% |
Profit Margin | 8.16% |
EBITDA Margin | 19.63% |
EBIT Margin | 14.94% |
FCF Margin | 7.99% |
Dividends & Yields
HCA pays an annual dividend of $2.7, which amounts to a dividend yield of 0.82%.
Dividend Per Share | $2.70 |
Dividend Yield | 0.82% |
Dividend Growth (YoY) | 9.09% |
Payout Ratio | 12.27% |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for HCA is $380, which is 13.4% higher than the current price. The consensus rating is "Buy".
Price Target | $380 |
Price Target Difference | 13.4% |
Analyst Consensus | Buy |
Analyst Count | 16 |
Scores
Altman Z-Score | 2.59 |
Piotroski F-Score | 6 |